The company logo for Roche Holding AG is seen on a glass doorway at the company's headquarters in Basel, Switzerland, on Wednesday, Feb. 1, 2017. Roche Holding AG is bracing for slower earnings growth this year as its ageing cancer blockbusters face competition and the Swiss drugmaker readies a new generation of medicines. Photographer: Michele Limina/Bloomberg via Getty Images
Getty Images

Bloomberg Bloomberg